S&P 500

5.304,72

0,70%

Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
Sigilon Therapeutics Inc (SGTX)
Sigilon Therapeutics Inc (SGTX) Notícias

SGTX

Sigilon Therapeutics (SGTX)

Sigilon Therapeutics Inc

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:NASDAQ:SGTX

1 2 3 Próxima >>

Data	Hora	Fonte	Título	Código	Companhia
21/08/2023	09:22	Edgar (US Regulatory)	Form 15-12G - Securities registration termination [Section 12(g)]	NASDAQ:SGTX	Sigilon Therapeutics Inc
16/08/2023	01:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:SGTX	Sigilon Therapeutics Inc
14/08/2023	08:25	PR Newswire (US)	Lilly Completes Acquisition of Sigilon Therapeutics	NASDAQ:SGTX	Sigilon Therapeutics Inc
11/08/2023	17:28	Edgar (US Regulatory)	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments	NASDAQ:SGTX	Sigilon Therapeutics Inc
11/08/2023	17:20	Edgar (US Regulatory)	Form POS AM - Post-Effective amendments for registration statement	NASDAQ:SGTX	Sigilon Therapeutics Inc
11/08/2023	17:16	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SGTX	Sigilon Therapeutics Inc
11/08/2023	17:10	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SGTX	Sigilon Therapeutics Inc
10/08/2023	09:31	Edgar (US Regulatory)	Form SC 14D9/A - Solicitation, recommendation statements: [Amend]	NASDAQ:SGTX	Sigilon Therapeutics Inc
07/08/2023	09:11	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:SGTX	Sigilon Therapeutics Inc
13/07/2023	09:18	Edgar (US Regulatory)	Form SC 14D9 - Solicitation, recommendation statements	NASDAQ:SGTX	Sigilon Therapeutics Inc
29/06/2023	08:35	Dow Jones News	Eli Lilly to Acquire Sigilon Therapeutics	NASDAQ:SGTX	Sigilon Therapeutics Inc
29/06/2023	08:04	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:SGTX	Sigilon Therapeutics Inc
29/06/2023	07:57	Edgar (US Regulatory)	Written Communication Relating to an Issuer or Third Party (sc To-c)	NASDAQ:SGTX	Sigilon Therapeutics Inc
29/06/2023	07:45	PR Newswire (US)	Lilly to Acquire Sigilon Therapeutics	NASDAQ:SGTX	Sigilon Therapeutics Inc
22/05/2023	17:21	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:SGTX	Sigilon Therapeutics Inc
22/05/2023	08:30	GlobeNewswire Inc.	Sigilon Announces Reverse Stock Split of Common Stock	NASDAQ:SGTX	Sigilon Therapeutics Inc
09/05/2023	09:11	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:SGTX	Sigilon Therapeutics Inc
09/05/2023	08:30	GlobeNewswire Inc.	Sigilon Therapeutics Reports First Quarter 2023 Financial Results and Business Highlights	NASDAQ:SGTX	Sigilon Therapeutics Inc
02/05/2023	10:00	PR Newswire (US)	Dimension Inx announces the addition of biotech industry leaders Paul K. Wotton, Ph.D., as Board Director and Chris Ehrlich as Senior Advisor	NASDAQ:SGTX	Sigilon Therapeutics Inc
18/04/2023	08:00	GlobeNewswire Inc.	Sigilon Therapeutics to Present at the Needham Virtual Healthcare Conference	NASDAQ:SGTX	Sigilon Therapeutics Inc
06/04/2023	08:07	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:SGTX	Sigilon Therapeutics Inc
06/04/2023	08:03	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:SGTX	Sigilon Therapeutics Inc
23/03/2023	18:01	Edgar (US Regulatory)	Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)	NASDAQ:SGTX	Sigilon Therapeutics Inc
14/03/2023	17:26	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:SGTX	Sigilon Therapeutics Inc
14/03/2023	17:15	GlobeNewswire Inc.	Sigilon Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Business Highlights	NASDAQ:SGTX	Sigilon Therapeutics Inc
01/03/2023	18:37	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:SGTX	Sigilon Therapeutics Inc
10/11/2022	09:30	GlobeNewswire Inc.	Sigilon Therapeutics Reports Third Quarter 2022 Financial Results and Business Highlights	NASDAQ:SGTX	Sigilon Therapeutics Inc
04/08/2022	17:30	GlobeNewswire Inc.	Sigilon Therapeutics Reports Second Quarter 2022 Financial Results and Business Highlights	NASDAQ:SGTX	Sigilon Therapeutics Inc
08/07/2022	17:58	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:SGTX	Sigilon Therapeutics Inc
12/05/2022	17:05	GlobeNewswire Inc.	Sigilon Therapeutics Reports First Quarter 2022 Financial Results And Business Highlights	NASDAQ:SGTX	Sigilon Therapeutics Inc